MedPath

Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .

Not Applicable
Recruiting
Conditions
High Myopia
Registration Number
NCT06596408
Lead Sponsor
Sohag University
Brief Summary

Study aiming to evaluate Macular Vascular Density in High Myopes without pathological myopic maculopathy in outpatient clinic in Sohag teaching hospital using OCTA .

Detailed Description

Study Design : This is a cross sectional observational study , of about 50 patients attending ophthalmology outpatient clinic at Sohag Teaching Hospital .

Inclusion criteria :

All myopic patients with axial high myopia (-6 spherical refractive error or more) attending the ophthalmology outpatient clinic .

Exclusion criteria :

The exclusion criteria will include :

* History of other any ocular diseases , systemic diseases that may affect the ocular circulation .

* Previous intraocular surgery or ocular injury .

* Any patient with pathological myopic maculopathy (epiretinal membrane, foveoschisis, macular holes, lamellar holes, Lacquers cracks, choroidal neovascularization and retinal atrophy ) .

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Outcome of evaluation of vascular density in high myopes6 month

Correlation between macular vascular density in high myopes and their :

Uncorrected visual acuity in diopters . Best corrected visual acuity in diopters . Spherical equivalent refraction that measured through this equivalent (spherical error + 1/2 cylindrical error ) .

Central macular thickness in micrometers .

To see how does ischemia affects vision in high myopes .

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

Sohag University
🇪🇬Sohag, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.